euro adhoc: november AG
Joint Ventures/Cooperation/Collaboration
november AG
- Insolvency proceedings opened as expected - continuation of companies secured
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
01.12.2006
Erlangen, 01 December 2006. Today, the main insolvency proceedings over the assets of the Erlangen based development and holding company november AG (ISIN DE0006762909) have been opened by the local court of Fürth. Attorney-at-law Volker Böhm, of firm Schultze & Braun, has been appointed as insolvency administrator. He has already led the proceedings in the preliminary phase and carried on negotiations with miscellaneous potential investors. In the meantime, the insolvency administrator has concluded a contract with a concrete investor, the Biomed group located in Freiburg, an enterprise known in the biotechnology and diagnostic sector, on the continuation of november group as a whole, consisting of november AG and the subsidiaries identif GmbH, directif GmbH, and PEQLAB Biotechnologie GmbH. Insolvency proceedings are to be terminated by beginning of 2007 by means of an insolvency plan. This would not, of course, concern PEQLAB.
An insolvency plan, which will render possible a speedy termination of the proceedings, will be established within the next few weeks.
end of announcement euro adhoc 01.12.2006 11:28:29
Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de
Branche: Biotechnology
ISIN: DE0006762909
WKN: 676290
Index: CDAX, Technologie All Share, Prime All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Börse Berlin-Bremen / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade